Antibodies targeting citrullinated proteins (ACPAs [anticitrullinated protein antibodies]) are commonly found in patients with rheumatoid arthritis (RA), strongly associate with distinct HLA-DR alleles, and predict a more aggressive disease course as compared with seronegative patients. Still, many features of these antibodies, including their site of production and the extent of MHC class II-driven T cell help, remain unclarified. To address these questions, we have used a single B cell-based cloning technology to isolate and express immunoglobulin (Ig) genes from joint-derived B cells of active RA patients. We found ~25% of synovial IgG-expressing B cells to be specific for citrullinated autoantigens in the investigated ACPA + RA patients, whereas such antibodies were not found in ACPA - patients. The citrulline-reactive monoclonal antibodies did not react with the unmodified arginine peptides, yet several reacted with more than one citrullinated antigen. A role for active antigen selection of the citrulline-reactive synovial B cells was supported by the strong bias toward amino acid replacement mutations in ACPA + antibodies and by their loss of reactivity to citrullinated autoantigens when somatic mutations were reverted to the corresponding germline sequences. © 2013 Amara et al.
CITATION STYLE
Amara, K., Steen, J., Murray, F., Morbach, H., Fernandez-Rodriguez, B. M., Joshua, V., … Malmström, V. (2013). Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. Journal of Experimental Medicine. Rockefeller University Press. https://doi.org/10.1084/jem.20121486
Mendeley helps you to discover research relevant for your work.